Literature DB >> 22208649

Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion -- interaction with the sensory system.

Anett Csati1, Janos Tajti, Bernadett Tuka, Lars Edvinsson, Karin Warfvinge.   

Abstract

Clinical studies have suggested a link between the sensory trigeminal system and the parasympathetic ganglia. Calcitonin gene-related peptide (CGRP) is a sensory neuropeptide which plays an important role in vasodilatation and pain transmission in craniocervical structures. The present study was designed to examine if CGRP and CGRP receptor components are present in the human sphenopalatine ganglion (SPG) in order to reveal an interaction between the sensory and parasympathetic systems. Indirect immunofluorescence technique was used for immunohistochemical demonstration of CGRP, the calcitonin receptor-like receptor (CLR) and the receptor activity modifying protein 1 (RAMP1) in human and rat SPG. Cryostat sections were examined and images were obtained using a light- and epifluorescence microscope coupled to a camera to visualize co-labeling by superimposing the digital images. In addition, Western blot technique was used to demonstrate the existence of CGRP receptor components in rat SPG. CGRP immunoreactive fibers were frequently found intraganglionic in the SPG in the vicinity of neurons. CLR immunoreactivity was observed in satellite glial cells (SGCs) as well as in nerve fibers, but not in neurons. RAMP1 immunoreactivity was localized in many neurons and SGCs. Thus, the two CGRP receptor components together were found in the SGCs. In addition, Western blot revealed the presence of RAMP1 and CLR in rat SPG. Our results suggest a possible sensory influence in the parasympathetic cranial ganglia. The sensory CGRP-containing fibers probably originate in the trigeminal ganglion, project to the SPG and act on CGRP receptors on SGCs.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22208649     DOI: 10.1016/j.brainres.2011.11.058

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521-1533.

Authors:  Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  Current understanding of trigeminal ganglion structure and function in headache.

Authors:  Karl Messlinger; Andrew F Russo
Journal:  Cephalalgia       Date:  2018-07-10       Impact factor: 6.292

3.  Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.

Authors:  Anne Luise H Vollesen; Agneta Snoer; Rasmus P Beske; Song Guo; Jan Hoffmann; Rigmor H Jensen; Messoud Ashina
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

4.  The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow.

Authors:  Mária Dux; Birgit Vogler; Annette Kuhn; Kimberly D Mackenzie; Jennifer Stratton; Karl Messlinger
Journal:  Cells       Date:  2022-05-28       Impact factor: 7.666

Review 5.  Role of sphenopalatine ganglion stimulation in cluster headache.

Authors:  Tim P Jürgens; Arne May
Journal:  Curr Pain Headache Rep       Date:  2014-07

Review 6.  Neurovascular contributions to migraine: Moving beyond vasodilation.

Authors:  Blaine Jacobs; Gregory Dussor
Journal:  Neuroscience       Date:  2016-06-14       Impact factor: 3.590

Review 7.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

8.  Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier.

Authors:  Rodrigo Noseda; Aaron J Schain; Agustin Melo-Carrillo; Jason Tien; Jennifer Stratton; Fanny Mai; Andrew M Strassman; Rami Burstein
Journal:  Cephalalgia       Date:  2019-12-19       Impact factor: 6.292

Review 9.  New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach.

Authors:  Irene Simonetta; Renata Riolo; Federica Todaro; Antonino Tuttolomondo
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.